Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 119

Results For "US"

8054 News Found

Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr
News | May 22, 2023

Zydus Wellness' FY23 consolidated net sales up 12.8% at Rs. 2243 Cr

Glucon-D, Sugar Free, EverYuth Scrub, Peel Off Face Mask and Nycil maintained their leadership positions in their respective categories as on March 2023


Strides Puducherry facility receives EIR  from USFDA
Drug Approval | May 20, 2023

Strides Puducherry facility receives EIR from USFDA

The USFDA had classified Strides Puducherry facility as OAI in May 2019 followed by issuing a warning letter to this site in July 2019.


Venus Remedies recognized for R&D excellence by DSIR
News | May 19, 2023

Venus Remedies recognized for R&D excellence by DSIR

Leading Research-driven Pharma Company Combats Antibiotic Resistance and Demonstrates Innovation in Medical Solutions


Hikal announces USFDA audit with zero observations
Drug Approval | May 16, 2023

Hikal announces USFDA audit with zero observations

This latest audit re-emphasizes Hikal's commitment towards maintaining the best in class quality, compliance and regulatory standards across our manufacturing sites


AiMeD welcomes Govt’s for assistance to medical devices clusters
Policy | May 16, 2023

AiMeD welcomes Govt’s for assistance to medical devices clusters

The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive


USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause
Drug Approval | May 13, 2023

USFDA approves Astellas' Veozah’ for treatment of vasomotor symptoms due to menopause

VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause


Sanofi India to demerge healthcare businesses
News | May 12, 2023

Sanofi India to demerge healthcare businesses

This decision will accelerate growth for both its pharma & consumer healthcare businesses in India


Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio
News | May 12, 2023

Lilly allocates additional US $50 million to Social Impact Venture Capital portfolio

The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries


USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’
Drug Approval | May 12, 2023

USFDA approves GSK’s respiratory syncytial virus vaccine ‘Arexvy’

Ground-breaking approval enables adults aged 60 years and older to be protected from RSV disease for the first time


AIIA and CCRAS jointly organised session for research and education in Ayush
News | May 11, 2023

AIIA and CCRAS jointly organised session for research and education in Ayush

Pandemic was the opportunity for Ayush to develop their science and Ayush did it by developing Ayush 64, etc